OPENLANE (NYSE:KAR – Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, November 6th. Analysts expect the company to announce earnings of $0.21 per share for the quarter. OPENLANE has set its FY24 guidance at $0.77-0.87 EPS and its FY 2024 guidance at 0.770-0.870 EPS.Individual that wish to listen to the company’s earnings conference call can do so using this link.
OPENLANE (NYSE:KAR – Get Free Report) last posted its quarterly earnings data on Wednesday, August 7th. The specialty retailer reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.02). The company had revenue of $431.80 million during the quarter, compared to analyst estimates of $426.11 million. OPENLANE had a return on equity of 7.85% and a net margin of 3.39%. OPENLANE’s revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.25 earnings per share. On average, analysts expect OPENLANE to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
OPENLANE Price Performance
OPENLANE stock opened at $16.20 on Tuesday. The stock’s 50 day moving average is $16.40 and its 200 day moving average is $16.93. The firm has a market cap of $1.76 billion, a P/E ratio of 108.00, a P/E/G ratio of 1.67 and a beta of 1.44. OPENLANE has a one year low of $12.86 and a one year high of $18.73.
Wall Street Analysts Forecast Growth
Get Our Latest Analysis on OPENLANE
OPENLANE Company Profile
OPENLANE, Inc, together with its subsidiaries, operates as a digital marketplace for used vehicles, which connects sellers and buyers in North America, Europe, the Philippines, and Uruguay. The company operates through two segments, Marketplace and Finance. The Marketplace segment offers digital marketplace services for buying and selling used vehicles.
See Also
- Five stocks we like better than OPENLANE
- When to Sell a Stock for Profit or Loss
- Intel: Is Now the Time to Be Brave?
- How to buy stock: A step-by-step guide for beginners
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for OPENLANE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OPENLANE and related companies with MarketBeat.com's FREE daily email newsletter.